Kevin L. Nickles
Keine laufenden Positionen mehr
Profil
Kevin L.
Nickles is President and Chief Executive Officer of Celleration, Inc. He was Chief Executive Officer of Kinesis Medical, Inc. from 1997 to 2000.
Prior to joining Celleration in 2000, Mr. Nickles was General Manager and Operations Director of Rosemount Aerospace, Inc. and Director of Operations, Research and Development for SciMed Life Systems, Inc. Previously, he held various operations and product development management positions at COBE Laboratories, Inc. and Cordis Dow BV.
Mr. Nickles received a BS degree in Mechanical Engineering from California State Polytechnic University.
Ehemalige bekannte Positionen von Kevin L. Nickles
| Unternehmen | Position | Ende |
|---|---|---|
Kinesis Medical, Inc.
 Kinesis Medical, Inc. Medical SpecialtiesHealth Technology Part of Orthofix Medical, Inc., Kinesis Medical, Inc. is a company that develops and manufactures orthopedic products. The company is based in Bloomington, MN. Kinesis Medical was acquired by Orthofix Medical, Inc. on August 30, 2000 for $6 million. | Präsident | 01.01.2000 |
| Cordis Dow BV | Corporate Officer/Principal | - |
| COBE Laboratories, Inc. | Corporate Officer/Principal | - |
SCIMED Life Systems, Inc. (Minnesota)
 SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Geschäftsführer | - |
Celleration, Inc.
 Celleration, Inc. Medical SpecialtiesHealth Technology Celleration, Inc. manufactured medical devices. It developed and marketed a proprietary technology to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. The firm’s core product was the MIST Therapy System, impacted all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. The company was founded by Gene Berghoff, Dennis L. Davey and Eliaz P. Babaev in 1999 and was headquartered in Eden Prairie, MN. | Präsident | - |
Ausbildung von Kevin L. Nickles
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Celleration, Inc.
Celleration, Inc. Medical SpecialtiesHealth Technology Celleration, Inc. manufactured medical devices. It developed and marketed a proprietary technology to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. The firm’s core product was the MIST Therapy System, impacted all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. The company was founded by Gene Berghoff, Dennis L. Davey and Eliaz P. Babaev in 1999 and was headquartered in Eden Prairie, MN. | Health Technology |
Kinesis Medical, Inc.
Kinesis Medical, Inc. Medical SpecialtiesHealth Technology Part of Orthofix Medical, Inc., Kinesis Medical, Inc. is a company that develops and manufactures orthopedic products. The company is based in Bloomington, MN. Kinesis Medical was acquired by Orthofix Medical, Inc. on August 30, 2000 for $6 million. | Health Technology |
SCIMED Life Systems, Inc. (Minnesota)
SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Health Technology |
| COBE Laboratories, Inc. | Health Technology |
| Cordis Dow BV |
